期刊文献+

超高效液相色谱-荧光检测法测定人体尿液中酪氨酸、对羟苯基乳酸和对羟苯基乙酸 被引量:3

Determination of Tyrosine,4-Hydroxyphenyllactic Acid and 4-Hydroxyphenylacetic Acid in Human Urine by Ultra-Performance Liquid Chromatography Coupled with Fluorescence Detection
下载PDF
导出
摘要 采用固相萃取技术,结合超高效液相色谱-荧光分析(UPLC-FLD)手段,建立了人体尿液中酪氨酸、对羟苯基乳酸和对羟苯基乙酸的同时测定新方法。系统探讨了不同机理下,应用固相萃取技术处理尿液的效果,最终选用Clean-Screen DAU混合固相萃取小柱处理尿液,成功地除去了大量干扰物质。在优化的实验条件下,上述三种化合物线性关系良好(R^2〉0.9996),检测限均为0.016mg/L。健康人和癌症病人尿液三个添加水平的平均回收率在86.9%~107.9%之间,相对标准偏差(RSD)小于2.8%。该方法快速、灵敏度高、选择性好,可用于人体尿液中三组分的同时测定。 A sensitive,rapid and practical method for simultaneous determination of tyrosine(Tyr),4-hydroxyphenyllactic acid(PHPLA)and 4-hydroxyphenylacetic acid(PHPAA)in human urine by ultraperformance liquid chromatography(UPLC)coupled with fluorescence detection(FLD)has been developed.The Clean-Screen DAU cartridge was employed to purify Tyr,PHPLA and PHPAA from human urine.The seperation of Tyr and its metabolites from other substances was carried on ZORBAX SB-C18 Rapid Resolution HD column with isocratic elution using 95∶5(V/V)mixture of 50 mmol/L ammonium formate buffer(pH=5.8,adjusted with formic acid)and acetonitrile at the flow rate of 0.20mL/min.Under the optimized condition,the limits of detection and limits of quantification for Tyr and its metabolites were 0.016 mg/L and 0.040 mg/L,respectively.Recoveries of Tyr and its metabolites in normal subjects and gastric cancer patients were in the range of 95.2%-107.8% and 86.9%-107.9%,respectively,with RSDs of 0.6%-2.8% and 0.5%-2.5%,respectively.The present method was successfully applied to the simultaneous determination of Tyr,PHPLA and PHPAA in human urine from healthy volunteers and gastric cancer patients.
出处 《分析科学学报》 CAS CSCD 北大核心 2015年第3期333-338,共6页 Journal of Analytical Science
基金 国家青年自然科学基金(No.21105043) 国家自然科学基金(No.21465017) 江西省自然科学基金(No.20122BAB203013)
关键词 酪氨酸 对羟苯基乳酸 对羟苯基乙酸 尿液 超高效液相色谱-荧光检测法 Tyrosine 4-Hydroxyphenyllactic acid 4-Hydroxyphenylacetic acid Human urine Ultra-performance liquid chromatography Fluorescence detection
  • 相关文献

参考文献19

  • 1Mak C M,Lam C W,Chim S,Siu T S,Ng K F,Tam S.Clinical Biochemistry[J],2013,46(1-2):155.
  • 2Phornphutkul C,Introne W J,Perry MB,Bernardini I,Murphey M D,Fitzpatrick D L,Anderson P D,Huizing M,Anikster Y,Gerber L H,Gahl W A.New England Journal of Medicine[J],2002,347(26):2111.
  • 3Russo P A,Mitchell G A,Tanguay R M.Pediatric and Developmental Pathology[J],2001,4(3):212.
  • 4Slupsky C M,Steed H,Wells T H,Dabbs K,Schepansky A,Capstick V,Faught W,Sawyer M B.Clinical Cancer Research[J],2010,16(23):5835.
  • 5Ma Y L,Liu W J,Peng J Y,Huang L,Zhang P,Zhao X P,Cheng Y Y,Qin H L.Molecular Biology Reports[J],2010,37(3):1403.
  • 6Kim J W,Lee G,Moon S M,Park M J,Hong S K,Ahn Y H,Kim K P,Paik M J.Metabolomics[J],2010,6(2):202.
  • 7Wu H,Xue R Y,Dong L,Liu T T,Deng C H,Zeng H Z,Shen X Z.Analytica Chimica Acta[J],2009,648(1):98.
  • 8Deutsch J C.Journal of Chromatography B[J],1997,690(1-2):1.
  • 9Letellier S,Garnier J P,Spy J,Bousquet B.Journal of Chromatography B[J],1997,696(1):9.
  • 10REN Ya-ping(任亚平),TANG Ai-guo(唐爱国),ZHOU Qian-xuan(周前选),XIANG Zhong-yuan(项忠元).检验医学[J],2010,25(10):756.

二级参考文献13

  • 1Pey AL,Desviat LR,Gamez A,et al.Phenylketonuria: Genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH[J].Hum Mutat,2003,21(4):370-378.
  • 2Levy PA,Miller JB,Shapira E.The advantage of phenylalanine to tyrosine ratio for the early detection of phenylketonuria[J]. Clinica Chemica Acta,1998,270(2):177-181.
  • 3J L Dhondt,J Loeber,L H Elvers,et al.Preparation of the first European working standard for phenylalanine determination in dried blood spots[J]. J Med Screen,1998,5:63-66.
  • 4J L Dhondt,E Paux,J P Farriaux.Need for a standardized procedure in the preparation of phenylalanine calibrators[J].Early Human Development,1996,45:277-285.
  • 5Pey AL,Desviat LR,Gamez A,et al.Phenylketonuria:Genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH[J].Hum Mutat,2003,21(4):370-378.
  • 6Ye J,Liu X,Ma X,et al.Screening for tetrahydrobiopterin deficiency among hyperphenylalaninemia patients in Southern China[J].Chin Med J(Engl),2002,115(2):217-221.
  • 7Kayler LK,Merion RM,Lee S,et al.Long-term survival after liver transplantation in children with metabolic disorders[J].Pediatr Transplant,2002,6(4):295-300.
  • 8Halaban R,Cheng E,Hebert DN.Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants[J].J Invest Dermatol,2002,119(2):481-488.
  • 9Morrow BA,Elsworth JD,Roth RH.Tyrosine enhances behavioral and mesocorticolimbic dopaminergic responses to aversive conditioning[J].Synapse,1996,22(2):100-105.
  • 10Allen KR,Degg TJ,Rushworth PA,et al.Measurement of phenylalanine and tyrosine in plasma by high-performance liquid chromatography using the inherent fluorescence of aromatic amino acids[J].Ann Clin Biochem,1999,36(Pt2):207-211.

共引文献15

同被引文献32

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部